Esperion Therapeutics
ESPR
#7380
Rank
A$0.57 B
Marketcap
$2.93
Share price
-0.53%
Change (1 day)
-28.19%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.23

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.44. In 2022 the company made an earnings per share (EPS) of -$5.59 an increase over its 2021 EPS that were of -$15.05.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.23-24.26%
2022-$5.59-62.87%
2021-$15.0580.38%
2020-$8.3450.14%
2019-$5.56-53.18%
2018-$11.877.41%
2017-$11.05110.81%
2016-$5.2447.35%
2015-$3.560.89%
2014-$3.5328.84%
2013-$2.74-89.3%
2012-$25.58
2002-$10.778.89%
2001-$9.90-83.77%
2000-$60.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$16.12 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.93-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.80-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.07-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA